Related Experiment Video
Updated: May 6, 2026

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
Bradykinin inhibits oxidative stress-induced cardiomyocytes senescence via regulating redox state
Ruolan Dong1, Xizhen Xu, Geng Li
1Department of Geriatric Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
Insights
Bradykinin (BK) protects against oxidative stress-induced senescence in heart cells. It reduces DNA damage and reactive oxygen species (ROS) by upregulating antioxidant enzymes and downregulating NADPH oxidase via nitric oxide (NO) release.
Area of Science:
- Cardiovascular Biology
- Cellular Aging
- Oxidative Stress Research
Background:
- Cellular senescence contributes to age-related diseases, including cardiovascular conditions.
- Cardiomyocyte senescence plays a role in age-related cardiovascular pathologies.
- Delaying cardiomyocyte senescence is crucial for managing cardiovascular diseases.
Purpose of the Study:
- To investigate the effect of bradykinin (BK) on H2O2-induced senescence in H9C2 cells.
- To elucidate the protective mechanisms of BK against oxidative stress in cardiomyocytes.
Main Methods:
- H9C2 cells were treated with H2O2 to induce senescence.
- Bradykinin (BK) pretreatment was applied in a dose-dependent manner.
- Senescence markers, DNA damage (comet assay), reactive oxygen species (ROS) production, and enzyme activities (SOD, NADPH oxidase) were assessed.
- The role of BK B2 receptor and nitric oxide (NO) was investigated using specific inhibitors.
Main Results:
- BK pretreatment dose-dependently decreased H2O2-induced senescence in H9C2 cells.
- BK significantly inhibited H2O2-induced increases in senescent cell number and p21 expression.
- BK markedly reduced DNA damage and ROS production induced by H2O2.
- The protective effects of BK were blocked by BK B2 receptor antagonist (HOE-140) and eNOS inhibitor (L-NAME).
- BK prevented the increase in NADPH oxidase activity and the decrease in SOD activity induced by H2O2, dependent on BK B2 receptor-mediated NO release.
Conclusions:
- Bradykinin (BK), acting via the BK B2 receptor and nitric oxide (NO) release, protects cardiomyocytes from oxidative stress-induced senescence.
- BK upregulates antioxidant enzymes (Cu/Zn-SOD, Mn-SOD) and downregulates NADPH oxidase activity.
- This leads to reduced ROS production and inhibition of senescence, offering a potential therapeutic strategy for cardiovascular diseases.
Background:
Cell senescence is central to a large body of age related pathology, and accordingly, cardiomyocytes senescence is involved in many age related cardiovascular diseases. In consideration of that, delaying cardiomyocytes senescence is of great importance to control clinical cardiovascular diseases. Previous study indicated that bradykinin (BK) protected endothelial cells from senescence induced by oxidative stress. However, the effects of bradykinin on cardiomyocytes senescence remain to be elucidated. In this study, we investigated the effect of bradykinin on H2O2-induced H9C2 cells senescence.
Methods And Results:
Bradykinin pretreatment decreased the senescence induced by H2O2 in cultured H9C2 cells in a dose dependent manner. Interestingly, 1 nmol/L of BK almost completely inhibited the increase in senescent cell number and p21 expression induced by H2O2. Since H2O2 induces senescence through superoxide-induced DNA damage, we also observed the DNA damage by comet assay, and BK markedly reduced DNA damage induced by H2O2, and moreover, BK treatment significantly prevented reactive oxygen species (ROS) production in H9C2 cells treated with H2O2. Importantly, when co-incubated with bradykinin B2 receptor antagonist HOE-140 or eNOS inhibitor N-methyl-L-arginine acetate salt (L-NAME), the protective effects of bradykinin on H9C2 senescence were totally blocked. Furthermore, BK administration significantly prevented the increase in nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity characterized by increased ROS generation and gp91 expression and increased translocation of p47 and p67 to the membrane and the decrease in superoxide dismutase (SOD) activity and expression induced by H2O2 in H9C2 cells, which was dependent on BK B2 receptor mediated nitric oxide (NO) release.
Conclusions:
Bradykinin, acting through BK B2 receptor induced NO release, upregulated antioxidant Cu/Zn-SOD and Mn-SOD activity and expression while downregulating NADPH oxidase activity and subsequently inhibited ROS production, and finally protected against cardiomyocytes senescence induced by oxidative stress.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Action of β1 Blockers
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Pathophysiology of Heart Failure
The Electron Transport Chain
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...

